During the past decade, Memphis Internal Medicine PLLC conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Memphis Internal Medicine PLLC" are "Acute Coronary Syndrome" (1 trials), "Coronary Artery Disease" (1 trials), "Diabetes Type 2" (1 trials), "Diabetic Neuropathy, Painful" (1 trials) and "Myocardial Infarction" (1 trials). Many other conditions were trialed in "Memphis Internal Medicine PLLC" in a lesser frequency.

Most popular intervention types in "Memphis Internal Medicine PLLC" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "70% insulin aspart protamine suspension and 30% insulin aspart injection (rDNA origin)" (1 trials), "CGT-2168 (clopidogrel 75 mg/omeprazole 20 mg) and aspirin" (1 trials), "Comparator" (1 trials), "Placebo" (1 trials) and "Plavix (clopidogrel 75 mg) and aspirin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Memphis Internal Medicine PLLC" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Memphis Internal Medicine PLLC". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Memphis Internal Medicine PLLC, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Memphis Internal Medicine PLLC, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".